Roland Stocker

Title: Roland Stocker: Innovator in Atherosclerotic Plaque Detection

Introduction

Roland Stocker is a prominent inventor based in Sydney, Australia. He has made significant contributions to the field of medical imaging, particularly in the detection of high-risk unstable atherosclerotic plaques. With a total of 2 patents to his name, Stocker continues to push the boundaries of innovation in healthcare.

Latest Patents

One of Stocker's latest patents is focused on the "Detection of high-risk unstable atherosclerotic plaque." This technology involves a method for identifying high-risk unstable atherosclerotic plaque in a subject. The method includes administering a magnetic resonance imaging (MRI) contrast agent that can be activated by myeloperoxidase (MPO) present in atherosclerotic plaque. After allowing the contrast agent to be activated, an image of the plaque is obtained using molecular MRI, where enhanced imaging indicates unstable plaque. In certain cases, an MPO inhibitor may also be administered to subjects identified as having high-risk unstable atherosclerotic plaque.

Another patent by Stocker is titled "Method for detection of potential co-antioxidants." This work further exemplifies his commitment to advancing medical research and improving patient outcomes.

Career Highlights

Stocker is affiliated with The Heart Research Institute Ltd., where he collaborates with other experts in the field. His work has been instrumental in developing innovative solutions for cardiovascular health.

Collaborations

One of his notable collaborators is Ann-Margret Lindqvist, with whom he has worked on various projects aimed at enhancing medical imaging techniques.

Conclusion

Roland Stocker is a key figure in the field of medical innovation, particularly in the detection of atherosclerotic plaques. His contributions through patents and collaborations continue to impact healthcare positively.